Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02607228
Title Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
San Francisco California 94158 United States Details
Baltimore Maryland 21231 United States Details
Boston Massachusetts 02114 United States Details
Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field